Featured Jobs
|
MAP Retirement
|
|
Plan Administrator, Defined Benefit & Cash Balance The Pension Source
|
|
Pattison Pension
|
|
Sentinel Group
|
|
Pension Investors Corporation
|
|
Defined Benefit Plan Consultant/Actuarial Analyst Sentinel Group
|
|
BPAS
|
|
Strategic Retirement Plan Consultant Retirement Plan Consultants
|
|
3(16) Retirement Plan & Customer Liaison Compass
|
|
MAP Retirement
|
|
DWC - The 401(k) Experts
|
|
Regional Vice President, Sales MAP Retirement
|
|
Retirement Relationship Manager MAP Retirement
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Biden Administration Pushes Anti-Obesity Drug Pressure to Trump
AXIOS; registration may be required 
Nov. 27, 2024 "The Biden administration's move, which would take effect in 2026, would expand access to drugs like Novo Nordisk's Ozempic or Wegovy for 3.4 million Americans on Medicare ... Officials said they do not expect this would raise seniors' premiums.... It's unclear how the Trump administration will view Medicare coverage of GLP-1s.... The cost is expected to be a key sticking point, particularly as the administration promises to cut back federal spending[.]" MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |